Clinical Trials List
2015-11-23 - 2022-04-01
Phase III
Terminated9
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Seu-Chun Yang Division of Thoracic Medicine
- Wen-Pin Su Division of Hematology & Oncology
- Sin-Syue Li Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Yau-Lin Tseng Division of Thoracic Surgery
- Yi-Ting Yen Division of Thoracic Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- CHAO-CHI HO CHAO-CHI HO Division of Thoracic Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- SHUENN-WEN KUO Division of Thoracic Surgery
- 楊景堯 Division of Thoracic Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Thoracic Medicine
- 陳冠宇 Division of Hematology & Oncology
- 廖唯昱 Division of Thoracic Medicine
- JANG-MING LEE Division of Thoracic Surgery
- 張逸良 Division of Others
- JIN-SHING CHEN Division of Thoracic Surgery
- 廖斌志 Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- 許嘉林 Division of Thoracic Medicine
- James Chih-Hsin Yang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- Hsu-ching Huang Division of Thoracic Medicine
- 蕭慈慧 Division of Thoracic Medicine
- 蔡俊明 Division of Thoracic Medicine
- Yung-Hung Luo Division of Thoracic Medicine
- Chao-Hua Chiu Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 曹朝榮 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- KUO-HSUAN HSU Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yi-Chen Wu Division of Thoracic Surgery
- Ping-Chih Hsu Division of Hematology & Oncology
- Chao Yin-Kai Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
- 枋岳甫 Division of Thoracic Medicine
- Chih-Hung Chen Division of Hematology & Oncology
- Chih-Liang Wang Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
- Cheng-Ta Yang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
163 participants
-
Global
700 participants
